University of Tennessee, Knoxville

TRACE: Tennessee Research and Creative
Exchange
Masters Theses

Graduate School

12-1994

Serum immunoglobulin concentrations in response to injectable
immunoglobulin in neonatal dairy calves
Melody L. Crawford

Follow this and additional works at: https://trace.tennessee.edu/utk_gradthes

Recommended Citation
Crawford, Melody L., "Serum immunoglobulin concentrations in response to injectable immunoglobulin in
neonatal dairy calves. " Master's Thesis, University of Tennessee, 1994.
https://trace.tennessee.edu/utk_gradthes/6942

This Thesis is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and
Creative Exchange. It has been accepted for inclusion in Masters Theses by an authorized administrator of TRACE:
Tennessee Research and Creative Exchange. For more information, please contact trace@utk.edu.

To the Graduate Council:
I am submitting herewith a thesis written by Melody L. Crawford entitled "Serum
immunoglobulin concentrations in response to injectable immunoglobulin in neonatal dairy
calves." I have examined the final electronic copy of this thesis for form and content and
recommend that it be accepted in partial fulfillment of the requirements for the degree of
Master of Science, with a major in Animal Science.
James D. Quigley III, Major Professor
We have read this thesis and recommend its acceptance:
Fred M. Hopkins, Michael O. Smith
Accepted for the Council:
Carolyn R. Hodges
Vice Provost and Dean of the Graduate School
(Original signatures are on file with official student records.)

To the Graduate Council:

I am submitting herewith a thesis written by Melody L.
Crawford entitled "Serum Immunoglobulin Concentrations in
Response to Injectable Immunoglobulin in Neonatal Dairy
Calves." I have examined the final copy of this thesis for
form and content and recommend that it be accepted in
partial fulfillment of the requirements for the degree of
Master of Science, with a major in Animal Science.

r.

_C—

Jai^s D. Quigleyy

ior Professor

We have read this thesis

and recommend its acceptance:

''r,ed M. Hopkins

fly'uol^d/ d"

cu

lichael O. Smith

Accepted for the Council:
Associate Vice Chancellor
and Dean of the Graduate School

STATEMENT OF PERMISSION TO USE

In presenting this thesis in partial fulfillment of the
requirements for a Master's degree at The University of
Tennessee, Knoxville, I agree that the library shall make it
available to borrowers under rules of the Library.

Brief

quotations from this thesis are allowable without special
permission, provided that accurate acknowledgement of the
source is made.

Permission for extensive quotation or reproduction of

this thesis may be granted by my major professor, or in his
absence, by the Head of Interlibrary Services when, in the

opinion of either, the proposed use of the material is for
scholarly purposes.

Any copying or use of the material in

this thesis for financial gain shall not be allowed without
my written permission.

signature

Date

h,

SERUM IMMUNOGLOBULIN CONCENTRATIONS IN RESPONSE TO
INJECTABLE IMMUNOGLOBULIN IN NEONATAL DAIRY CALVES

A Thesis
Presented for the

Master of Science
Degree

The University of Tennessee, Knoxville

Melody L. Crawford
December 1994

to

DEDICATION

This thesis is dedicated to Nancy Kinder, whose love,

support, and continued encouragement allowed me
to spread my wings and fly.

11

ACKNOWLEDGEMENTS

The author would like to thank the following

individuals for contributions to her study at The University
of Tennessee, Knoxville:

To Dr. J. D. Quigley, III, my deepest thanks for

serving not only as my major professor, but also as my
friend and guide through the graduate school process.

Thank

you for your encouragement, philosophical ideas, and

challenges which allowed me to grow both intellectually and

professionally.

I will always be indebted to you for your

time and patience concerning my research and the writing of
this thesis.

To Drs. F. M. Hopkins and M. O. Smith I would like to

express my gratitude for serving as members of my graduate

committee.

Your encouragement and suggestions concerning

this thesis and my course of study are greatly appreciated.
To Clyde Holmes, Mark Campbell and the personnel of the

Dairy Unit of the Knoxville Experiment Station many thanks
for assistance in obtaining animals, equipment, and
supplies.

Your cooperation and help were invaluable to this

study.

To Kim Martin my deepest thanks for teaching me how to
raise calves and collect and analyze samples.

Also, for

being a tremendous help and supportive friend during the
study and the preparation of this thesis.

To Kim Lawler, Kris Krishnamoorthy, Geoffrey Strickler
iii

and Alison Brown much appreciation for your dedicated care
and feeding of the animals.

To Dr. M. Drew and American Protein Corporation many

thanks for providing both financial and technical support to
this study.

To the University of Tennessee Department of Animal

Science sincere gratitude for believing in me, encouraging
me, and funding my studies.

Special thanks to Lila Uehlein, Glenndora Robinson,
Michelle Vaughn, and Joan Presnell for your clerical

expertise and help, in addition to your encouragement and
friendship during this test of endurance.
To Kellie Fecteau and Michael Rowland for your love,

friendship, and encouragement without which I never would
have survived.

Finally, thanks to my family for your love, moral

support, and belief in me. A special thanks to Suzette and

Lydia. Although it is sometimes difficult being the "big"
sister, you make it worth the effort.

You are my reasons

for striving to achieve more than the minimum.

IV

ABSTRACT

Thirty Holstein bull calves were used to investigate
the use of an injectable solution of purified iminunoglobulin
(Ig) to increase serum Ig in neonatal calves.

Immunoglobulins were obtained from bovine abattoir blood

separated and purified by sodium polyphosphate precipitation
followed by an ammonium sulfate precipitation.

Calves were

blocked by date of birth and assigned randomly to treatment
within block.

Treatments were subcutaneous injections of

.9% NaCl without colostrum feeding, Ig (30 mg of Ig/ml) in

Lactated Ringer's Injection without colostrum feeding, Ig

(30 mg of Ig/ml) in .9% NaCl without colostrum feeding, Ig
(60 mg of Ig/ml) in .9% NaCl without colostrum feeding, and
injection of .9% NaCl with feeding of 4 L of pooled

colostrum by 24 h of age.

of age.

All calves were injected by 24 h

Mass of Ig injected was 1.05 g/kg of body weight.

Calves receiving colostrum were fed 2 L of pooled colostrum

as soon as possible after birth and at 12, 24, and 36 h of

age. All other calves were fed commercial milk replacer in
the same manner.

Blood was sampled at 0, 48 h post-

injection, and 28 d of age and serum was analyzed for IgG
and IgM by radial immunodiffusion.

Mean serum IgG and IgM

in calves injected with Ig were 4.2 and .7 g/L,

respectively, and were higher than in calves receiving no

Ig.

Mean serum IgG and IgM concentrations in calves fed

colostrum were higher than in other calves and were 14.6 and

1.0 g/L, respectively.

Two calves died during the study.

Subcutaneous Ig increased levels of serum Ig, however,
further research is needed to accurately delineate optimal
amounts of Ig to infuse.
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Part I

INTRODUCTION

Neonatal morbidity and mortality are factors which
contribute to economic losses in food-animal production.

In

1992, a U.S. survey reviewing dairy heifer health and

management, reported that 8.4% of heifers born alive or

brought onto an operation died before weaning (15).

It is

widely accepted that neonatal management is critical to the
survival and subsequent production of the animal (29, 32,

58).

Therefore, management of calving facilities, calving

practices, housing, feeding, colostral management, and
primary person caring for calves are related to calf

mortality (32, 58).

However, high rates of morbidity and

mortality have been specifically associated with low
circulating concentrations of immunoglobulin (Ig) in the
serum of the calf (15, 29).

Calves are born hypogammaglobulinemic, (9, 29, 58) a
condition which is characterized by low concentrations of

serum Ig, and immunity to pathogens is obtained via
colostrum, the first mammary secretion of the cow post-

partum.

Colostrum provides the neonate with greater

concentrations of nutrients, including proteins, fats,

vitamins, and minerals, than do other mammary secretions.
Colostrum also provides the calf with immunological
components, including Ig, lymphocytes, complement,
lactoferrin, and lysozymes, which give temporary

immunological protection until active immunity is mature.
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Passive transfer of Ig from colostrum provides protection to

the calf against pathogens to which the cow has been exposed
and, as a general rule, provides protection against those
organisms to which the calf will be exposed (57).

Absorption of Ig occurs in the small intestine where

epithelial cells absorb macromolecules and transfer them via
the lymphatic system to the general circulation (66).

In

calves, intestinal absorption of Ig is limited by age of the
calf and varies with isotype of Ig.

Mean cessation of

absorption is 24 h post-partum (68), therefore, it is
imperative that sufficient quantities of Ig be ingested by
the calf as soon as possible after birth.

Through changes in neonatal and colostral management,
survival rates have increased in recent years.

Unfortunately, high incidences of failure of passive
transfer still occur, and herds have been reported with as

many as 40% of calves with failure of passive transfer (29).
However, the National Dairy Heifer Evaluation Project

reported that 22% of the total calf deaths in the U.S. could
be avoided by providing the neonate with sufficient Ig prior
to cessation of macromolecular uptake (15).

Although improvements in colostral management have

been made, incidences of failure of passive transfer will
continue.

Therefore, techniques are needed which will

provide calves with passive immunity after 24 h of age.
Currently, plasma transfusions and the use of donor plasma
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are being used by some veterinarians to treat calves with
failure of passive transfer (1), and although these methods
can be effective, they are also costly and time consuming,

and require technical assistance to be administered.

Recently, a purified form of injectable Ig from bovine
plasma has been developed for administration to the

hypogammaglobulinemic calf. The objective of this project
was to evaluate the effectiveness of using this solution to

provide passive immunity to hypogammaglobulinemic calves.
Subcutaneous injection was chosen as route of

administration, as it may be readily incorporated into
normal calf management by producers.

Part II

LITERATURE REVIEW

NEONATAL MORBIDITY AND MORTALITY

Calf morbidity and mortality are of constant concern

to dairy producers.

Estimates of calf mortality in U.S.

dairy herds range from a low of 6.5% to as high as 22.0%,
economic losses to mortality are considerable (36).

Death

losses occur most frequently during the first month post-

partum when the neonate's immune system is most vulnerable
(31, 36, 54).

Although losses from morbidity are also very

costly, they may be less apparent than death losses.
However, decreased herd productivity and herd health have
been linked to illnesses in young stock (32).

High rates of morbidity and mortality have been
associated with neonatal management and, in particular,
colostral management, as calves are born

hypogammaglobulinemic and must receive immunity from
colostrum.

Low circulating levels of antibodies, or

immunoglobulin (Ig), in the sera may predispose the animal

to a greater risk of scours and/or respiratory disease which
are the leading causes of morbidity and mortality in
neonatal calves (15, 58).

Both conditions are highly

correlated with management and Ig status of the calf, and
may be reduced by careful neonatal management.
Costs Associated with Neonatal Morbidity and Mortality
Costs of neonatal mortality in the state of Tennessee

have been estimated to exceed $5 million annually (Quigley,

7

personal coraraunication).

In addition, high mortality rates

are very costly to individual producers.

Martin et al. (49)

reported that operations whose calf mortality rate was 20%
would lose 38% of total net profit.

In addition to losses

of animals and genetic potential, consideration must be

given to costs of feeding, care, and treatment associated
with morbid calves (58).

Costs associated with

gastrointestinal and respiratory diseases were estimated to
be $33.46 and $14.71 per calf per year, respectively (37).
Overall profitability could be significantly increased by
reducing losses incurred from these diseases.
Morbidity of the young calf may adversely affect herd
health and subsequent production (32, 64).

Calfhood

morbidity may also decrease rate of gain (49), days to first
calving and long-term survival (10, 19).

Management Factors Associated with Morbidity and Mortality
Neonatal management is critical in decreasing

morbidity and mortality of dairy calves.

Through careful

management of young stock, particularly during the preweaning phase, potential future production, and subsequently
future profitability, could be increased.

Management

practices, including calving area, perinatal care, colostrum
management, housing, feeding, herd size, and primary care

giver have been associated with calf morbidity and mortality
(32). However, for most significant improvement, changes in
several factors must be made.

Of primary importance are;
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1) minimizing exposure to pathogens by insuring clean

calving areas, calf housing and feeding equipment, and 2)
maximizing Ig intake by insuring that adequate quality and
quantities of colostrum are ingested by the calf within the
first 24 h post-partum (28).

THE NEONATAL CALF

At birth, neonates are exposed to a wide variety of
infectious organisms including bacteria, viruses and
protozoa (43).

Entrance into the body may be through the

mucosal surfaces of the digestive, respiratory, or

urogenital tracts, via the umbilical cord, or through an

injury or wound to the skin (41).

These agents, known as

antigens, are recognized as foreign to the body by immune
cells called lymphocytes.

Various phagocytic cells

including macrophages and neutrophils respond by migrating
to the site of insult and engulfing the antigen to
facilitate the elimination from the body (30).

The ability

of the bovine neonate to protect itself from an antigenic
invasion is poor and is associated with certain
characteristics of ruminant immunological development (74).
The Immune System

Mammals possess both specific and non-specific defense
mechanisms for immunological protection against pathogenic

organisms (43).

Non-specific mechanisms are physical or

chemical barriers to invasive substances with which the body
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comes in contact.

These barriers include skin, epithelial

tissues, mucosal surfactants, other internal and external
secretions, and normal body flora (41).

Non-specific

mechanisms primarily function to prevent entry of diseasecausing organisms into the body.

Specific defense

mechanisms are capable of recognizing and selectively

eliminating antigens (41).

All immune responses of this

mechanism display specificity for the antigen, diversity of
elimination or neutralization, memory in response to a given

antigen, and self/nonself recognition of the antigen (41).
Specific immunity is comprised of both humoral and cellmediated immunity (Fig. 1).

Cells of each system arise from common lymphoblasts of
the bone marrow, while each takes a different path in

processing the antigen (Fig. 2).

Two major groups of cells,

lymphocytes and antigen-presenting cells, participate in the
generation of an immune response.

Lymphocytes are a type of

white blood cell produced in the bone marrow which circulate

in blood and lymph, mediating the attributes (specificity,
diversity, memory and self/nonself recognition) of specific
immunity (41).

In addition, antigen recognition occurs by

way of specific membrane receptors for that antigen.
Lymphocytes may be classified as either B-lymphocytes or Tlymphocytes.

Antigen presenting cells (APC) present antigen
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fractions in association with special membrane proteins,
called major histocompatibility complex (MHC), after antigen
degradation.

These cells include macrophages, dendritic

cells, and B-lymphocytes.

Pathway of processing and

presentation is dependent upon the form of antigen being
processed.

Exogenous antigen, or antigen produced outside

the host, is processed via the endosomal processing pathway.

Endocytosed or phagocytosed antigen is broken down via
lysozymes inside the effector cell.

Binding of antigenic

peptide fragments with MHC occurs inside a vacuole.

This

complex is exported to the surface of the cell where it
reacts with effector T-cells to increase immunity to the

antigen and eliminate it from the body.

Endogenous

antigens, or antigens produced within the body, undergo

degradation within the cytoplasm of the AFC.
virus-infected and cancer cells.

These include

Peptide fragments of the

antigen become associated with MHC in the endoplasmic
reticulum.

The peptide-MHC complex is presented on the

surface of the APC and binds with cytotoxic T-lymphocytes to
destroy the altered self-cell.

Humoral Immunity

Humoral immunity is that immunity associated with body
fluids, such as plasma and lymph, or those substances
contained in them (73).

Effector molecules of humoral

immunity include Ig and complement (43).

Humoral immunity

involves the differentiation and proliferation of B-
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lymphocytes after contact with an antigen.

In ruminants, B-

lymphocytes, or B-cells, may originate in gut-associated
lymphoid tissue in the intestinal wall, termed Peyer's
patches, as well as in bone marrow (58, 74).

As B-cells

encounter antigens, rapid proliferation and differentiation
begin.

Differentiation results in the establishment of two

cell lines with specificity for the given antigen.

These

lines are comprised of memory B-cells and plasma cells.
Memory B-cells express the membrane-bound antibody of the
parent cell and have a long lifespan to ensure continued
protection against the antigen.

In contrast, plasma cells

produce secretory Ig and live for only a few days while
producing large quantities of Ig specific for the given
antigen (41, 43).

These Ig bind to the antigen and

neutralize or facilitate its elimination.

with Ig may be eliminated in several ways.

Antigens coated

Antigen-antibody

complexes can form clusters which are readily ingested by

phagocytic cells (41).

In addition, this complex may

activate the complement system resulting in lysis of the
foreign organism (41).

Neutralization occurs when Ig coat

the antigen and prevent its subsequent binding to the host
cell (41, 63).

Humoral immunity may be passed from one individual to
another (30, 41, 43).

This involves the administration of

serum antibodies from an immune individual to one lacking
those specific antibodies.

In calves and many other
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Antibodies produced in the mammary gland of the dam or
secreted into colostrum from serum are ingested by the
neonate and absorbed intact, providing much needed

immunological protection.

Immunity gained in this manner is

called passive immunity (30).
Cellular Immunity

Cellular immunity, in contrast to humoral immunity,
utilizes specific cells, rather than cellular products, as
the effectors of immunity (30, 43, 60, 63).

Effector cells

include those specific for antigen, such as T-lymphocytes,
as well as, non-specific effectors, such as macrophages,

neutrophils, eosinophils and natural killer cells (60, 63).

Like B-lymphocytes, T-lymphocytes, macrophages, neutrophils,
eosinophils and natural killer cells also arise from stem
cells of bone marrow.

However, T-cell maturation occurs in

the thymus where membrane-bound receptors for antigen are
expressed.

Unlike membrane-bound receptors of B-cells,

which recognize antigen alone, T-cells receptors may only

recognize foreign antigen in conjugation with a specialized
surface protein, major histocompatibility complex (MHC), on
the antigen presenting cell (41, 63).

Elimination of antigen by cellular immunity, may occur

by two methods:

1) combination of nonspecific effector

cells with antibody (antibody-dependent cell-mediated

cytoxcicity; ADCC) (41, 60, 63), or 2) mediated by specific

T-lymphocytes (cell-mediated immunity; CMI) without the aid
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of Ig (41, 60, 63).

Neutrophils, monocytes and other

cytotoxic cells act as the effector or killer cells of ADCC.
In this system, the effector cells possess membrane bound

receptors for the Fc region of Ig which is bound to the

target antigen.

When Fc region and receptor join, secretion

of various substances (e.g., lytic enzymes, tumor necrosis

factor, perforin) by the nonspecific cytotoxic cells,
destroy the antigen (41).

Cell-mediated immunity involves the activation of T-

lymphocytes by the conjugation of MHC and antigen.

Contact

of T-cell with MHC-antigen complex initiates the

proliferation and differentiation of T-cells into memory Tcells and effector T-cells.

Memory T-cells, like memory B-

cells, function to expand the progeny of each lineage of Tcell to speed and heighten levels of subsequent

immunological responses to that antigen.

Effector T-cells

function in mediating the immune response and may be

categorized into two subpopulations:

and T-cytotoxic (Tc) cells.
antigen-MHC complex.

T-helper (Th) cells

The Th cells are activated by

Upon activation, these release

lymphokines which enhance both humoral and cell mediated
immunity.

Lymphokines may inhibit or stimulate macrophages,

the production of Ig by plasma cells, and inhibit growth and
cytotoxic effects of natural killer cells, monocytes and
leukocytes (43, 63).

The Tc cells react to MHC-antigen

complexes under the direction of Th derived lymphokines.
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These cells proliferate and differentiate into cytotoxic Tlymphocytes which function in monitoring and eliminating
self cells displaying antigenic behavior such as virusinfected cells, tumor cells and tissue graft cells (41).

Cell-mediated immunity plays an important role in protection
against intracellular bacteria, viruses, cancer, or other
altered self-cells, and graft rejection through degradation
and phagocytosis of the antigen (41, 43, 60, 73).
Antibodies

As stated earlier, antibodies are protein molecules

produced as a result of the interaction of antigen-sensitive
B-cells with specific antigen.

They may be found in serum,

lining mucous membranes, and in other body fluids where they
bind to antigen and hasten its elimination from the body
(30, 41, 74).

Physio-chemical Characteristics of Antibodies
Proteins may be classified on the basis of their
solubility in strong salts, electrostatic charge, molecular
weight, and antigenic determinants (74, 75).

Through these

methods, biochemists have developed the current
classification of antibodies (74).

Solubility

Proteins may be separated by precipitation in strong
salts.

Proteins which precipitate are called globulin and

those that remain in solution albumin (30, 74).

Serum when

mixed with an equal volume of ammonium sulfate results in
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the precipitation of proteins, or globulin, from the
supernatant which contains albumin (74).

The globulin

portion of serum contains those proteins which display
immunologic activity.

This simple technique may be adapted

to provide a method for determining whether or not certain
neonates, such as calves, pigs, and horses, have obtained
antibodies from colostrum (33, 74).

Electrostatic Charge

When serum is subjected to electrophoresis, it
separates into four distinct fractions (74, 75).

negatively charged fraction is serum albumin.

The most

The other

three fractions consist of globulin and may be further

divided based upon their electrophoretic mobility.
fractions are classified a, 6, and y (41, 74).

These

The a-

globulins are the most negatively charged fraction of
globulin and consist of proteins with non-immunological
activity including inhibitors of proteases, Ox-antitrypsin
and tta-macroglobulin (74).

The B-globulins are less

negatively charged than a-globulins and contain some
antibodies (41, 74).

However, they primarily consist of

proteins which make up the complement system for cell lysis.
The most positively charged fraction of globulin are y~
globulins (41, 74).

This fraction contains most of the

antibodies of the immune system called immunoglobulins
because they display immunological activity (30).
Immunoglobulins will be the primary focus for discussion of
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molecular weight and antigenic structure.
Molecular Weight

The molecular weight of Ig found in body secretions is
somewhat variable (74).

Serum Ig have a molecular weight of

around 180,000 daltons, although approximately 20% have a

molecular weight of 900,000 daltons, while those Ig found in
secretions of intestinal and respiratory tracts have a

molecular weight of 360,000 daltons (11, 74).

This

variability suggests the need for further classification.
Antigenic Structure

The heterogeneity of Ig is most evident by its
antigenic structure (41, 74).

When Ig of one species are

injected into other species, they act antigenically and
stimulate the production of antibodies to the foreign Ig.
By using the newly formed antibodies, called antisera (30),
Ig may be classified into different isotypes.

The

antibodies of the antisera are sensitive to differences in

major epitopes on the molecule.

These epitopes are

designated y, /i, a, 6, and e delineating Ig isotypes.

In

cattle, there are three predominant isotypes of Ig; IgG,

IgM, and IgA.

The IgG molecule may be further classified as

IgGi and IgGa (11/ 58, 74).

Basic chemical and biological

characteristics of these isotypes are described in Table 1.
Structure of Immunoglobulins

Although, different classes of Ig exist, certain
structural characteristics remain constant between isotypes
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Table 1.

Chemical and biological characteristics of

bovine iramunoglobulin.

Item

IgG

IgM

IgA

Molecular Weight^

180,000

900,000

360,000

Half life, days^

27

2

4

Closure, h^'®

27

22

16

Endogenous production,
days of age^

14

7

7

^Molecular weight (74).

^Half life, closure and endogenous production (23).
^Cessation of absorption of Ig through the wall of the
small intestine.
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(43, 74).

Using the IgG molecule as a model (Fig. 3), these

similarities may be studied.

Through the use of electron

microscopy the Y-shape of the IgG molecule is revealed (74).
The "arms" of the molecule are capable of binding antigen
and the "tail" able to bind to lymphocytes or cytotoxic

cells (11, 41, 43, 74).

IgG consists of four protein

chains, two identical light chains (approximately 25,000
daltons each) and two identical heavy chains (between 50,000

and 70,000 daltons depending on isotype), covalently linked
by disulfide bonds (11, 30, 41, 74).
subdivided into domains.

Each chain may be

Light chains consist of two

domains whereas, heavy chains consist of four or five
domains according to the class of Ig to which it belongs
(11, 30, 41, 74).

Domains may be either constant or

variable in nature.

The constant domains of the heavy chain

determine the class or isotype of the Ig molecule (41, 43).

The variable domains of the light chain comprise the antigen

binding site of the Ig molecule, providing antigen
specificity (41, 43, 74).

Fragmentation of the molecule by

proteolytic enzymes allows for closer examination.
Treatment of IgG with papain yields three large fragments;

two identical fragments still capable of binding antigen
called Fab fragments and one fragment consisting of the
"tail" incapable of binding antigen but is crystalizable
called the Fc fragment (41, 43, 74).

In addition, the

intact molecule may be treated with pepsin which results in
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Schematic drawing of immunoglobulin molecule.

Main

structural features are the variable (V) and constant (C)

domains of the heavy (H) and light (L) chains.

Variable

regions of the H and L chains, form antigen binding sites of

the molecule while constant regions define the isotype to
which it belongs (41).
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the destruction of the Fc region but leaves the Fab regions
intact (11, 41, 43, 74).

The Fab regions joined together

are termed F(ab)2' and are still capable of antigen binding

(11, 41, 43, 74).

The Fab portions of the molecule consist

of both a light and heavy chain constant and variable

region.

The Fc portion of the molecule consists of two

constant domains of the each heavy chain (11, 41, 43, 74).

This region contains carbohydrate groups and cell-binding
effector segments which are recognized by Fc receptors on

lymphocytes and cytotoxic cells enabling opsonization,
complement activation, and ADCC to occur (43).
Tuimiinoqlobulin G

The most abundant Ig found in the bovine belongs to

the class IgG (11, 74).

Of the Ig found in serum and

lacteal secretions (Table 2), 86% belong to the class IgG

(12).

IgG are relatively small in size (180,000 MW), and

are monomeric in both membrane-bound and secreted forms (11,

41, 74)(Fig. 4).

Due to its small size, IgG possess the

ability to leave the blood and provide immunological
protection in extracellular spaces and body surfaces (11,

74).

For this reason, it is a major effector in ADCC (41,

51).

When IgG binds to an antigen, the Fc region may

interact with some components of complement.

This activates

the complement system which, in turn, releases chemotactic
factors to attract cytotoxic cells to the area of insult.
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Table 2. Immunoglobulin levels in bovine external
secretions and serum^.

Protein Concentration (mg/ml)
Item

IgA

IgG,

IgG,

IgM

Lacrymal

2.6

.3

.12

.006

Saliva

1.95

.04

.025

trace

Gastrointestinal
Secretions

.24

.25

.06

trace

Colostrum

4.4

75

1.9

trace

Milk

.05

.35

.06

.04

Serum

.3

10.5

7.9

2.5

Secretions

^Adapted from (58).
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Fig. 4.

General structures of three types of imiiiunoglobulin

found in the bovine.

The polymeric chains of IgM and IgA

contain a polypeptide known as the J chain. Secreted IgM is
always a pentamer and most serum IgA exists in monomeric
form. Secretory IgA, however, exists as a dimer (41).
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These cells include neutrophils and macrophages which

possess Fc receptors for IgG.

Subsequent binding to the

antigen-antibody complex initiates phagocytosis or lysis of
the foreign cell (51).

IgG also plays a major role in secondary response to

an antigen (41).

Activation of B-cells during the initial

exposure to antigen, or primary response, results in
proliferation and differentiation of memory B-cells and
plasma cells.

At this time, plasma cells produce large

quantities of Ig, primarily IgM, for a short period
immediately following the insult.

However, memory B-cells

go into a dormant phase until additional stimulation by the
antigen occurs.

Due to somatic mutation of memory B-cells

during the primary response, isotype switching has occurred.
The subsequent activation of these cells results in the

production of antibodies of varying isotype and biological
effector function (i.e., protection of mucosa, protection of
circulation, or protection of extracellular spaces) (41).

The secondary response to antigen is characterized by a more
rapid and heightened response and the secretion of

antibodies with a greater affinity for the antigen including
a greater proportion of IgG (41).

IgG may be further divided into 2 subclasses: IgGi and

IgGa.

These isotypes are classified by differences in

epitopes and electrophoretic mobility (41, 74).

IgGi

functions in complement fixation and skin sensitization (12,
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51), whereas IgGais responsible for selective binding of

neutrophils and macrophages for lysis and phagocytosis of
antigen (51).

All subclasses of IgG possess the ability to

opsonize and precipitate antigen (41, 74).
Timniinoglobulin M

IgM is found in second highest concentration in the
serum of most animals (74) and accounts for 12% of serum Ig

and 7% of colostral Ig in cattle (12).

It is the largest of

the Ig molecules with a molecular weight of 915,000 daltons
(11, 74).

IgM is composed of five identical monomers, each

180,000 daltons, similar in structure and shape to IgG (11,
41, 74) (Fig. 4).

The monomers are linked by disulfide

bonds forming a circular molecule.

In the center of the

molecule two monomers are held together by a cysteine-rich

polypeptide chain called the J chain.

This is an integral

part of the molecule and is secreted intact by plasma cells
(74).

Due to its large size, pentameric IgM is essentially
confined to the circulatory system, and is primarily
responsible for protection against septicemias.

IgM may

also be found in monomeric membrane-bound form expressed on

B-lymphocytes where they function as antigen receptors (23,

41, 74).

In addition, IgM is the initial isotype

synthesized in primary response to antigen.

IgM is also

present in the secondary response yet, may be masked by the
predominance of IgG (41, 74).
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TTmniinnqlobulin A

The third predominant type of Ig found in bovine
secretions is IgA (11, 74).

IgA accounts for only 2% of

serum Ig (12), and in humans and rats, IgA is the

predominant Ig found in lacteal secretions.

However, in the

ruminant, IgA comprises 7% of the total Ig (12).
This molecule exists in polymeric forms such as

dimers, trimers and higher polymers (41, 74) (Fig. 4).

However, IgA most commonly exists as a dimer, consisting of
two monomers, structurally similar to IgG, joined by a J
chain (41, 74) with a molecular weight of 320,000 daltons.

The Fc region is tightly folded and held together by many
disulfide bonds, and subsequently resists proteolytic
degradation (74).

Plasma cells synthesize IgA in the intestinal mucosa
where it binds to a receptor and is endocytosed, transported

across the mucosal epithelial cell, and exocytosed into the
intestinal lumen.

When this complex reaches the intestinal

lumen, IgA and some of the receptor are cleaved to release

IgA with approximately 75% of the receptor still intact.
This fragment, called secretory component, has a molecular

weight of 71,000 daltons and gives IgA greater resistance to
proteolytic degradation, enabling it to protect the mucosa
of the digestive tract (74).

The primary function of IgA is in protecting mucosal
surfaces against antigenic substances (11, 12, 23, 41, 74).
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IgA is concentrated in saliva, intestinal fluids, secretions
of the respiratory, gastrointestinal, and urogenital tracts,
tears, milk, and colostrum (41, 74).

IgA coats the surface

of bacteria and viruses, as well as epithelial surfaces,

preventing their adherence to the body (41, 74).

TRANSMISSION OF IMMUNITY PRE-PARTUM

Bovine neonates are born with fully developed immune

systems yet, are unable to defend themselves against
infection by pathogenic organisms.

Susceptibility to

microorganisms seems to be linked to the unprimed state
rather than to the immaturity of their immune system (74).

Primary lymphoid organs, including thymus and bone marrow,

develop early in gestation and are recognizable at 41 and 58
days after conception, respectively (74).

Secondary lymph

organs, such as lymph nodes, are found at 60 days, and IgG

and IgM may be found in serum by 150 days post-conception
(74).

Development in the protected environment of the uterus
leaves the calf with little antigenic stimulation of its

immune system and consequently, very low levels of serum Ig

(38, 74).

To protect itself from pathogens, the calf must

receive Ig from another source.

In mammalian systems, this

immunity, known as passive immunity, is provided by the dam.
Route of transfer is determined by structural aspects of the

placenta.

In humans and primates, the placenta is
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hemochorial (9, 74).

In this system maternal blood is in

direct contact with the trophoblast and allows maternal IgG

to be transferred to the fetus, providing protection against

septicemias.

In ruminants, however, the placenta is

syndesmechorial, allowing chorionic epithelium to contact
uterine tissues directly inhibiting the passage of Ig from
maternal blood to fetal blood (9, 73, 74).

These animals

are born hypogammaglobulinemic and must receive passive
immunity by other means.

Hypogeunmaglobulinemia

Hypogammaglobulinemia is an immunological state
characterized by abnormally low levels of serum Ig (3).
This condition, which may be classified as primary,

secondary, or physiological (3), increases an animal's
susceptibility to infectious disease.

Primary

hypogammaglobulinemia, an inherited condition due to a

genetic defect, inhibits Ig synthesis, while secondary
hypogammaglobulinemia, is acquired and retards or ceases

production of endogenous Ig in the body (3). Physiological
hypogammaglobulinemia occurs when little or no production of
endogenous Ig has occurred, primarily due to the young age
of the animal (3).

Physiological hypogammaglobulinemia occurs in neonates

of many domesticated animal species (3, 9). Certain
neonates, including calves, foals, pigs, sheep and goats, do
not receive antibodies from their dam in utero and must
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receive them after birth.

Young will remain

hypogammaglobulinemic until sufficient ingestion and
absorption of colostrum or endogenous production of Ig
begins (3, 9).

Inadequate ingestion of colostrum soon after

birth results in the neonate remaining hypogammaglobulinemic

and consequently, at great risk of life-threatening
infections.

This condition, known as failure of passive

transfer (FPT), is the most common immunodeficiency disease

among domesticated animals and is especially prominent in
foals and dairy calves (3, 9, 29).

TRANSMISSION OF IMMUNITY POST-PARTUM

Transmission of immunity to the calf can occur for

only a brief period of time post-partum, as intact
antibodies from colostrum may only be absorbed by the small

intestine within approximately the first 24 h of age (68).

During this time, transfer of Ig from colostrum to the blood
occurs without the alteration or modification of the

molecule (9, 58, 74).

Changes in the digestive tract of the

neonate inhibit its ability to absorb immunologically active

Ig (9, 58).

Cessation of macromolecular transport from the

lumen of the intestine to the blood is called closure (44,

45, 66).

After closure occurs, the gut ceases to absorb

macromolecules and chances of acquiring passive immunity
from the dam are terminated (65).
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Colostrum

Colostrum is the first lacteal secretion produced by

the dam after parturition, encompassing the first six
milkings post-partum (27, 43).

Colostrum provides the

neonate with greater concentrations of nutrients, including
proteins, fats, vitamins, and minerals, than do other

mammary secretions.

In addition, colostrum provides the

calf with immunological components, including Ig,

lymphocytes, complement, lactoferrin, and lysozymes, which
gives temporary immunological protection until active
immunity is mature (9, 27, 43, 74).

Immunological factors

of colostrum are derived from both maternal serum as well as

being synthesized by mammary tissue (43, 58).

Perinatal

calves possess a limited ability to digest food due to the
immaturity of enzymatic and acid producing cells of the
digestive tract (9, 74).

Therefore, neonatal calves are

dependent upon the concentrated nutrient components and

immunological factors of colostrum to sustain them until

digestive ability increases and immunological competence is
gained.

Concentrations of various components of colostrum

are in Table 3.

These will vary with age, breed and

production level of the cow.

Colostrum synthesis begins in the mammary gland during
the last trimester of gestation (9, 27, 43).

During this

time, Ig are transferred from serum to colostrum (9).
Transfer of Ig from serum to colostrum is accomplished
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Table 3. Various component concentrations of colostrum
(27).

Number of milkings post-partum
Item

1

2

3

4

5

Total solids (%)

23.9

17.9

14.1

13.9

13.6

6

1

6.7

5.4

3.9

4.4

4.3^

Casein (%)

14.0

8.4

5.1

4.2

4.1^

Albumin (%)

.9

1.1

.9

.7

.4

Immunoglobulins (%)

6.0

4.2

2.4

IgG (g/100 ml)

3.2

2.5

1.5

NPN (% of total N)

8.0

7.0

Lactose (%)

2.7

Ash(%)

1.1

Total protein (%)

.4

• • •

•••

•• •

•••

•• •

•••

8.3

4.1

3.9

4.0

3.9

4.4

4.6

4.7^

.9

.9

.8

.8^

^Composite of milkings 5 and 6,

33

without the degradation or resynthesis of Ig molecule, and
is the primary source for IgG and IgM in colostrum (2, 9,

58, 74).

Some Ig synthesis, however, does take place in

mammary tissues.

Plasmocytes, or Ig-synthesizing cells in

the mammary gland, produce small amounts of IgG and IgM and

approximately 60% of the total IgA found in colostrum (58).
Colostrum contains 81% IgGi, 5% IgGa, 7% IgM, and 7% IgA

(12).

The higher proportion of IgG in comparison to other

Ig classes (in particular, IgGi) is due to the preferential
secretion of this Ig isotype under regulation of the hormone

estrogen (11, 55), as IgG is needed to provide protection
against systemic infections.

Absorption of Immunoglobulin
Absorption of intact Ig occurs due to several factors
associated with the neonatal digestive tract.

Parietal

cells, which secrete HCL, are low in number from birth to
three days, increasing rapidly thereafter (9, 21, 58, 74).
The lack of HCL secretion renders the small intestine with a

near neutral pH.

Since a low pH is reguired for

proteolysis, degradation of colostral proteins such as Ig is
prevented (9, 21, 58, 74).

The absence of proteolytic

activity facilitates the absorption of undegraded Ig.

In

addition, secretion of proteolytic enzymes by the pancreas

is limited during the first 24 h after birth.

Pancreatic

amylase, lipase and proteases are all low in the first few h
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of life, increasing during the first week, and thereafter
stabilizing (9, 58).

Iiamunoglobulins are contained in the whey portion of
colostrum.

As colostrum enters the abomasum, a clot forms,

separating fat and casein from the whey phase of colostrum
(18).

Whey, containing Ig, reaches the small intestine soon

after feeding, resulting in absorption prior to digestion by

pancreatic enzymes.

The ability to form an abomasal clot is

an important factor in effective absorption of IgG during
the first 6 h post-partum (9, 18).
A factor in colostrum which aids in the absorption of

Ig is colostral trypsin inhibitor.

Trypsin, the major

proteolytic enzyme secreted by mammals, has been shown to be
inhibited by colostral trypsin inhibitor in swine, therefore
allowing Ig to pass undegraded to epithelial cells of the
small intestine where absorption takes place (14).

Concentrations of trypsin inhibitor are high in colostrum

but decrease rapidly after parturition.

This decrease in

trypsin inhibitor, along with decreases in abomasal pH of
the calf, allow degradation of Ig to begin (58).
Mechanism of absorption

In calves, macromolecules ingested within the first 24

h post-partum, may be absorbed by intestinal epithelial
cells by way of an apical tubular system (66).

Absorption

involves the intracellular transport of macromolecules from
the lumen of the small intestine to the lymphatics and
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villous blood capillaries.

This ability is closely related

to the structure of the cells where absorption takes place
(50, 66).

Absorption occurs in three steps:

First, Ig arrive at

the binding site of the microvillus border of the small
intestine.

It binds to the receptor, and receptor and Ig

are endocytosed by pinocytosis into the epithelial cell.
Second, a vacuole is formed from the endocytosed membrane,
vacuolar contents are condensed, and the vacuole migrates

through the cytoplasm where it contacts the lateral or basal
membrane of the cell.

Third, the vacuole and its contents

are exocytosed into the lamina propria and villous blood

capillaries, and are transported to general circulation
(66).

Debate exists as to selectivity of absorption of

various Ig isotypes.

In general, it is believed that

macromolecular uptake in the calf is non-selective, since
levels of Ig in calf serum are proportional to those levels

in colostrum ingested (58, 74).

Differences in duration of

absorption and proportion of isotype, however, suggest some

selectivity in absorption of Ig isotype (46, 66).
Location of Absorption

Utilizing "®I-labeled IgGi, absorption of Ig has been
shown to occur in the distal portion of the small intestine
of the calf (24).

The greatest absorption seems to occur

near the duodenal-cecal junction, progressively decreasing

36

toward the abomasum (35).

Colostrum fed before 6 h of age

seems to be absorbed by all villous cells of the small
intestine.

However, by 53 h of age, only those cells at the

tips of the villi are able to transport Ig (58).

Loss of

capability to absorb intact molecules progresses with each
generation of epithelium (58).
Closure

The ability to acquire passive immunity via absorption
of colostral Ig is limited in calves, pigs, and foals.

The

cessation of macromolecular transport from the intestinal
lumen to general circulation is known as closure (44, 45,

66).

In calves, closure occurs at approximately 24 h post-

partum, although, efficiency of absorption declines from 12
h post-partum (69, 70).

Several hypotheses have been

suggested explaining the regulation of closure.

Staley and

Bush (66) suggest regulation is through the development of

an intracellular digestive system.

Their hypothesis is

based on differences of acid phosphatase levels (an

indicator of lysosomal enzymes) in the preclosure and

postclosure jejunal cells of pigs and rats.

The presence of

lysosomal enzymes in postclosure epithelial cells suggests
that uptake of Ig may continue however, intracellular
digestion may occur prior to exocytosis into the lymph or

portal blood.

The replacement of vacuolated epithelial

cells with mature non-vacuolated epithelial cells in the

lamb and pig has also been suggested as a possible regulator
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of closure (50, 58).

In addition, it has been suggested

that colostral feeding stimulates pinocytosis by epithelial
cells (58).

Intestinal epithelial cells have a limited

capacity for endocytosis and closure occurs when this is
exhausted.

Physiological differences in species

experiencing closure would suggest the possible presence of

separate inducers for closure.

However, further research is

needed to determine if this is true.

Several factors seem to be associated with time of

closure.

Time of closure varies with Ig isotype (46, 58).

Closure to IgM is 16 h, IgA is 22 h and IgG is 27 h post-

partum (46) suggesting the existence of an independent
mechanism for isotype absorption.

Hence, delay of colostral

feeding could result in the deficiency of a particular
isotype.
Closure is also related to time of first feeding.

As

colostrum feeding is delayed, closure is also delayed until
spontaneous closure, which occurs at approximately 32 h
post-partum (68).

A decrease in absorption with delayed

feeding has also been reported.

As feeding is delayed,

plasma Ig decreases linearly.

The presence of intestinal flora may affect the

absorption of Ig.

Bacteria compete with Ig for absorption,

degrade Ig, and accelerate epithelial cell migration along
the villi, reducing closure time (58).

The establishment of

intestinal flora prior to colostrum feeding hinders both
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absorption of Ig, due to competition between microbes and Ig
for epithelial receptors (66), and effectiveness of
colostrum in inhibiting colonization by bacteria (34, 47).
James et al. (34) reported that calves inoculated with
duodenal fluid before first colostral feeding, had serum

concentration of 5.3 g/L of Ig as opposed to 12.4 g/L in
calves not inoculated.

Dam Factors Affecting Absorption of Immunoglobulin
Several factors associated with the dam have been

shown to influence Ig absorption in calves.

These include

concentration of Ig in colostrum, presence of dam at
feeding, and prepartum feeding of the dam.
Colostral Ig concentration has been shown to affect

absorption of Ig by the calf.

Although some experiments

have shown that increasing concentration of Ig fed at first

feeding has no bearing on rate of absorption (39, 40, 70),
it has been suggested that these experiments may have
limited inference for this parameter due to narrow ranges of

colostral Ig or confounded by varying quantities of
colostrum fed at different ages (67).

More recent studies

have shown that as colostral Ig concentration increased,

total absorption of Ig also increased (58, 67).
Presence of the dam has also been shown to influence

colostral Ig absorption in calves.

Calves fed colostrum

either by bottle or bucket in the presence of their dam
absorb more Ig than calves fed equal amounts of colostrum.
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yet reared in isolation (21, 22, 61, 62).

Reasons for this

difference have yet to be proven, although a definite
relationship does exist.

Beef cows who experienced reduced protein intakes

during the last third of gestation showed significantly
lower concentrations of IgGi and IgGa absorbed by their

calves (7).

Proper feeding of animals during gestation is

necessary for proper development of offspring.

In this

case, absorption may have been decreased by the

underdevelopment of jejunal cells which are responsible for
Ig absorption (58).

Calf Factors Affecting Absorption of Immunoglobulin
Considerable debate exists as to whether birth body

weight of the calf influences Ig absorption.

Stott et al.

(70) suggested that birth weight does not effect colostral

absorption.

However, others report that birth weight is a

significant factor in colostral absorption (39) and many
colostral feeding recommendations suggest feeding volumes in
relation to birth weights (5, 48).

In addition, others have

suggested that heifer calves, who tend to have lower birth
weights than bull calves, absorb larger amounts of Ig (58).

Conflicting results indicate the need for additional studies
in this area.

Failure of Passive Transfer

Morbidity and mortality of the young calf may be due
to a lack of colostral intake, or to the absence of a
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particular antibody in colostrum ingested (29).

Although

this might have been true in some incidences, most cases
involve FPT (25, 29, 58).

Calves with serum IgG concentrations less than 10

mg/ml at 48 h of age are considered to experience FPT and
are at a markedly higher risk of susceptibility to
infectious disease (29, 58).

However, calves whose serum

IgG concentration is greater than 10 mg/ml may be

susceptible to infectious disease as well.

Differences in

calf management, stocking rate, infection pressure, and
prevalence of disease organisms, as well as prevalence of

specific antibodies in colostrum, contribute to the amount
of Ig needed to reduce the risk of infection (8, 29).

In

addition, differences in mortality rates may be attributed
to differences in rearing method (29).

Even though colostrum may be fed to the neonate, it is

possible that up to 40% of calves in herds experience FPT
(29).

Several factors have been associated with FPT in

calves, including inadequate ingestion of colostrum, low
concentrations of Ig in colostrum, age at feeding first
colostrum, and early closure or loss of macromolecular

absorptive ability in the small intestine (29, 68, 69, 70,
72).

Quality of Colostruin

Colostral Ig concentration may be used as a measure of

colostrum quality (5, 26). A negative correlation exists
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between apparent efficiency of absorption and concentration
of colostral Ig (4).

However, calves fed lower volumes of

high quality colostrum, greater than or equal to 50 mg/ml
(26), have higher serum Ig concentrations than those fed
larger volumes of low quality colostrum.
Quantity of Colostrum

Acquisition of adequate passive transfer of immunity
is dependent upon consumption of a sufficiently large volume
of colostrum to provide a sufficient mass of Ig for

absorption.

Volume of colostrum has a direct influence upon

mass of Ig fed (5).

Feeding 4 L of high quality colostrum

by 12 h of age is recommended to facilitate acquisition of
passive transfer. However, Stott et al. (71) reported that
Holstein calves left to nurse the dam consumed an average of
2.4 L of colostrum in the first 24 h.

This amount is

clearly insufficient to provide the calf with adequate
levels of circulating Ig.

Therefore, to ensure that

adequate volumes are fed, calves should be fed via nipple
bottle, bucket or esophageal feeder.
Diagnosis of Failure of Passive Transfer
Several tests have been developed which may be used to

diagnose FPT in the neonate.

These include both

quantitative and qualitative analyses. Quantitative tests,
such as zinc sulfate turbidity, sodium sulfite

precipitation, glutaraldehyde coagulation, and serum total
protein are inexpensive, easy to perform, and give rather
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immediate results allowing diagnosis and treatment before
the animal becomes ill (20, 33).

In addition, single radial

immunodiffusion and enzyme-linked immunoabsorbant assays may

be used to quantitate as well as qualitatively analyze serum
Ig from calves (41).

Although these tests have a greater

sensitivity for Ig, they are more costly and time consuming
and delay diagnosis and treatment of the animal.
Methods of Providing Immunoglobulin Post-closure

Bovine plasma and serum transfusions have been shown
to be useful in the treatment of FPT in calves (1).

However, these methods of providing passive immunity postclosure are expensive, time-consuming and require technical
assistance to administer.

A recent study evaluated the use

of Ig from whey to provide passive immunity against

rotavirus (6).

Calves receiving subcutaneous injections of

whey extracted from the colostrum of cows immunized against
rotavirus, were protected from rotavirus.

Additionally, in

an evaluation of the use of a purified bovine Ig from
abattoir blood to increase serum Ig levels in colostrum

deprived calves (17).

Subcutaneous injections of Ig did

increase serum Ig concentrations in colostrum-deprived
calves.
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Part III

SERUM IMMUNOGLOBULIN CONCENTRATIONS IN RESPONSE TO
INJECTABLE IMMUNOGLOBULIN IN NEONATAL DAIRY CALVES
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INTRODUCTION

Morbidity and mortality of the neonatal calf are of
significant economic concern to beef and dairy producers.

A

recent national dairy heifer survey (5) reported that

preweaning mortality of heifer calves born alive or moved
onto an operation was 8.4% (SE = .4).

Losses include the

cost of the animal, investments in feed, housing, health
care, and labor.

Calves are born hypogammaglobulinemic, therefore

consumption of colostrum is required to provide passive
immunity until the calf's own immunity is established (4).

For approximately 24 h after parturition, intestinal
epithelial cells absorb macromolecules such as Ig (19, 20),
which are transported through the cell, to the lymphatic
system, and then to the general circulation (4, 19).
Thereafter, absorption of macromolecules ceases and chances

of acquiring passive immunity are terminated.

If calves do

not ingest a sufficient mass of Ig prior to cessation of
macromolecular transport, increased morbidity and mortality

may occur (7, 16, 19).

Klaus et al. (11) reported that 30%

of calves consuming colostrum may remain

hypogammaglobulinemic.

More recently, a USDA survey (5)

reported that 41% of 2,177 calves sampled between 24 and 48
h of age failed to attain serum IgG concentration of 10 g/L.
Further, it was estimated that 53.6% of mortality risk among
calves with serum IgG concentration less than 10 g/L was
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associated with inadequate Ig transfer and colostral intake.

The degree of acquisition of passive immunity is dependent
upon several factors, including age at first colostral
feeding and mass of Ig intake (12, 20).

Therefore,

techniques are needed to provide Ig to hypogammaglobulinemic
calves after cessation of macromolecular transport by

intestinal epithelium.

Techniques such as serum

transfusions are possible but are difficult, time consuming,

and costly.

Development of purified Ig preparations (3, 6)

have potential to provide Ig via injection with lower cost.

Our objective was to investigate the use of an injectable
solution of purified Ig as a source of Ig for

hypogammaglobulinemic calves.

MATERIALS AND METHODS

Animal Assignments and Experimental Design

Thirty Holstein bull calves were blocked by date of

birth and assigned randomly within block to one of five
treatments.

Treatments were subcutaneous (SQ) injections of

.9% NaCl (Neg, Pos), Ig (30 mg of Ig/ml) in Lactated

Ringer's Injection (L30), Ig (30 mg of Ig/ml) in .9% NaCl
(S30), and Ig (60 mg of Ig/ml) in .9% NaCl (S60).

Calves on

Neg, L30, S30, and S60 treatments were fed 4 L of milk
replacer by 24 h of age and calves on Pos treatment were fed
4 L pooled colostrum by 24 h of age.
by 24 h of age.

Calves were injected

Volume of solution administered was
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calcula'ted to provide serum Ig concentration of 15 g/L.
Serum volume was assumed to be 7% of BW (18).

Volume of

solution administered was calculated as the mass of Ig to

inject divided by Ig concentration in the solution.
The Ig solution (American Protein Corporation, Ames,
lA) was obtained from bovine abattoir blood, separated and

purified using two chemical precipitation reactions.

Plasma

was obtained from fresh bovine blood by centrifugation.

Serum was acquired by the removal of fibrin and clotting
factors through the addition of calcium chloride and

followed by filtration.

A solution of 1.25% sodium

polyphosphate was added to the serum.

The pH was adjusted

to 3.95 using 25% phosphoric acid and solution centrifuged
to remove precipitate.

adjusted to 7.2.

The pH of the supernatant was then

A second precipitation followed using

ammonium sulfate (18% wt/vol) to precipitate the Ig
fraction.

This was resolubilized and dialyzed against

phosphate buffered saline via difiltration.

The solution

was sterile filtered using a .22 micron filter and preserved
using .02% Merthiolate.
The solution was obtained in three lots, and averaged

6.2% total protein (SE = .05) and 6.1% IgG (SE = .04).

The

Ig solution was diluted in .9% NaCl or Lactated Ringer's
Injection and delivered by SQ injection.

Large amounts of

solution (> 1 L) were delivered by multiple injections.
Calves on Pos and Neg treatments were injected with .9% NaCl
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using volumes for 30 mg/ml treatment.

Subcutaneous

injection was chosen as route of administration because this
route of injection would be more readily incorporated into
the management of calf growers.

Many calf raisers routinely

provide SQ electrolytes to neonatal calves purchased from
sale barns and transported long distances.

Saline and

Lactated Ringer's Injection were used to compare the effect
of diluent on absorption of fluid and Ig by the calf.
Animal Management

Pregnant cows were housed in a drylot 2 weeks prior to
calving and allowed on pasture during the day.
occurred in the drylot or pasture.

Calving

Calves remained with the

dam for a limited time to be cleaned and stimulated but were

monitored closely and not allowed to nurse the dam.

Navels

were dipped in 7% iodine solution at the birth site.

As

soon as possible after birth calves were moved to the

experimental facility, weighed, and placed in an individual

pen (2 X 2 m) bedded with shavings. Pens were cleaned daily
and shavings replaced each week.
Calves were housed in an enclosed room used for animal
metabolic studies.

Since calves were brought to the

experimental facility prior to receiving Ig, all equipment
and surfaces with which the calves would come in contact
were steam cleaned and disinfected using a 50/50 mixture of

chlorine bleach and water prior to the initiation of the

study. Pens were again disinfected after each animal
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completed the study. Feeding equipment was scrubbed in hot
soapy water and disinfected after each use.

In addition,

fans were used for ventilation and to control temperature

during the first two months of the study, which began in
late August and ended in late December.

Even with such

precautions, the environment was not sterile, and some
immunological challenge did exist.

However, calves lacked

the same level of immunological challenge that they would
have received had this been conducted under normal farm

conditions.

Calf mortality, however, was not the focus of

this experiment and precautions were justifiable due to the
nature of the study.

Feeding Hanagement

Calves on L30, Neg, S30, and S60 treatments were fed 2

L of milk replacer (Maxi-Lac; Tennessee Farmers Cooperative,
LaVergne, TN) upon arrival and at 12 h intervals until 48 h
of age.

Calves on Pos treatment were fed 2 L of pooled

colostrum (mean IgG =41.1 g/L, SE = 8.2) upon arrival and
at 12 h intervals until 48 h of age.

Colostrum was obtained

from multiparous Holstein cows, pooled and stored at —20°C.
Frozen colostrum was thawed in warm water.

first feeding was 1.5 h (SE = .2).

Mean age at

Thereafter all calves

received milk replacer reconstituted to 14% DM at 10% of BW

in two equal feedings at approximately 0800 and 1600 h.
Amount of milk replacer offered was adjusted weekly.
Commercial calf starter (Co-op Starter/Grower Course - Dec;

56

Tennessee Farmers Cooperative) was offered for ad libitum

consumption once daily from 4 d of age.

Amounts of milk

replacer and starter consumed were measured at each feeding.
Water was available at all times.

Feed Sampling and Analysis

Samples of pooled colostrum (100 ml) were collected
and stored (-20°C) until duplicate analysis of IgG and IgM

by radial immunodiffusion (VMRD Inc., Pullman, WA).

Samples

were diluted (10:1) with .9% NaCl prior to analysis of IgG
but without dilution for IgM analysis.

Samples were

incubated at room temperature for approximately 20 h and

precipitant rings were measured using an ocular micrometer
on a stereomicroscope.

Samples of milk replacer and calf starter were
collected weekly.

Samples were grouped each month and the

resulting composite mixture was analyzed for DM, CP, ash,

ether extract (1), NDF (8), Ca, P, Mg, and K (atomic
absorption spectrophotometry)(Table 4).
Blood Sampling and Analysis

Jugular blood (approximately 10 ml) was collected into
evacuated containers (without anticoagulant) at 0 and 48 h

post—injection and 28 d of age.

Blood was allowed to

coagulate and serum was separated by centrifugation (3,000 x

g) and stored (-20°C) prior to duplicate analysis of IgG and
IgM by radial immunodiffusion as described for colostrum but
without dilution.
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Table 4.

Chemical composition of milk replacer and calf

starter.

Milk replacer^

Item

Mean

DM, %

95.3

SE

.2

Calf starter
Mean

89.1

SE
.5

(% of DM)—
CP

Ash
NDF

Ether extract

20.0

.5

17.8

.1

9.6

.1

7.6

.2

•••

22.6

.6

3.8

.2

ND^
17.6

.2

Ca

.56

.02

1.23

.05

P

.71

.01

.73

.02

K

2.30

.02

1.29

.03

.17

.01

.36

.01

Mg
^n = 4.
^'n = 3.

®Not determined.
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Indicators of Health

Fecal consistency was scored at the a.m. feeding by
the method of Larson et al. (13).

Signs of respiratory

infections and other disorders were recorded daily.

Rectal

temperatures and respiration rates were measured once daily
at the a.m. feeding.

Statistical Analysis

Serum Ig concentrations at 48 h post-injection and 28

d were analyzed as a randomized complete block experimental
design by analysis of covariance, using IgG, and IgM at 0 h
as covariables.

Weekly intake of starter and milk replacer,

BW, feed efficiency, mean rectal temperatures, fecal scores,
and respiration rates were analyzed by repeated measures

analysis of covariance using a randomized complete block

design. Significance at P < .05 was used unless otherwise
indicated.

RESULTS AND DISCUSSION

Morbidity and Mortality

Two calves died during the study.
death occurred at less than 1 wk of age.

In both incidences
Necropsy

determined that death was caused by septicemia.

Calves were

from treatments L30 and Neg and were not replaced.

Therefore, least squares means are presented.

Respiration rates tended to be affected by an age by
block interaction (P < .10), which may have been due to
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changes in ambient temperature during the study which began
in late summer and ended in early winter.
rate was 36 breaths per minute (SE = 1).

Mean respiration
Rectal

temperatures tended to be affected by age of calf (P < .10)
but were unaffected by treatment.

Mean rectal temperature

was 38.6°C.

Calves injected with SQ Ig tended to experience less
severe scouring than calves on Neg treatment (P < .10) but
scours scores did not differ from calves on Pos treatment.

Mean scours scores were 1.3 and 1.6 for calves injected with

SQ Ig and Neg treatments, respectively. Mean days scouring
(fecal score > 3) did not differ by treatment and was 3.7 d
(SE = .9).

Absorption of fluid and Ig from the injection site

normally reguired approximately 9.8 h from the beginning of
first injection until all solution was absorbed.

Complete

absorption was determined when no visible fluid remained in
the injection area. There was no obvious difference between
diluents or concentration of Ig solution on rate of

absorption.

Occasionally, the injected solution appeared to

migrate ventrally along the side of the calf, possibly as a
result of the density of the solution.

Injections made near

the shoulder tended to allow accumulation of material in the

joints producing mild discomfort to the animal when walking.
This effect was short term lasting less than 2 days, and may
have been the result of the presence of salts not removed
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during Ig purification process.
BW, Intake, and Feed Efficiency
No effects of treatment were observed on BW at 28 d,

average daily gain, intake of calf starter, DM, CP, or feed
efficiency (Table 5).

However, calves on Pos treatment

tended to have lower initial BW (P < .10) than other calves

which resulted in lower consumption of DM and CP from milk

replacer.

Changes in intake and BW with increasing age were

unaffected by treatment and were indicative of normal intake
and growth for calves during the first month of life.
Calves deprived of colostrum during the first 24 h
postpartum often experience increased morbidity and
mortality (5, 7, 18, 20) and reduced BW gain and intake
(16).

These data suggest that depressions in BW gain and

intake in calves deprived of colostrum may be more a

function of disease exposure than to one or more components
of colostrum.

Our calves were strictly isolated from other

animals, and strict hygiene practices were followed.

Intake

of feed and BW gain were similar between calves fed
colostrum, calves injected with Ig solution, and those

remaining hypogammaglobulinemic.
Serum Immunoglobulin

Serum IgG and IgM concentrations at 0 h were

consistently below the minimum limits of the radial
immunodiffusion assay and indicated that the calf had not
suckled the dam prior to being transported to the

Table 5. Least squares means of intake, BW gain and feed efficiency.
Contrasts

Treatment^
Neg

Item^

L30

S30

S60

Pos

SE

1

2

3

4

BW at Birth, kg

42.3

42.8

44.0

43.0

39.2

1.8

NS*

t

NS

NS

BW at 28 d, kg

51.4

50.8

51.9

53.1

48.2

2.0'

NS

NS

NS

NS

247

299

283

360

324

60

NS

NS

NS

NS

Total

588

602

578

617

571

32

NS

NS

NS

NS

Starter

117

145

104

155

142

27

NS

NS

NS

NS

Replacer

471

457

474

462

429

15

NS

■k

NS

NS

115

117

114

121

111

6

NS

NS

NS

NS

Starter

21

26

19

28

25

5

NS

NS

NS

NS

Replacer

94

91

95

93

86

3

NS

*

NS

NS

BW gain:DM
intake, g/d

406

502

496

584

567

87

NS

NS

NS

NS

BW gain:CP
intake, g/d

2077

2571

2524

2999

2911

452

NS

NS

NS

NS

BW gain, g/d
DM intake, g/d

CP intake, g/d
Total

'Treatments were subcutaneous (SQ) injections ofs .9% Nad without colostrum feeding (Neg), Ig (30 g/L) in Lactated Ringer's
Injection (L30), Ig (30 g/L) in .9% Nad (S30), Ig (60 g/L) in .9% NaCl (S60), .9* NaCl with colostrum feeding.
^Contrasts! 1 = SQ Ig treatments vs. Neg, 2 = SQ Ig treatments vs. Pos, 3 = 30 g/L vs. 60 g/L, 4 = Saline vs. Lactated Ringer's
Injection at 30 g/L.

'Means are covariatley adjusted for BW at birth, except BW at birth.
*P > .lOj

< .10; *P < .05.

'SE for L30 and Neg: BW at 28 d = 2.2, total DM intake - 36, starter DM intake = 30, replacer DM intake = 17, total CP intake = 7,
BW gain:DM intake = 98, BW gain:CP intake = 506.
<y\
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experimental facility.

Serum IgG concentration at 48 h among calves receiving
SQ Ig treatments was greater than serum IgG in calves on Neg
treatment (P < .01; Table 6).
not different at 28 d.

However, concentrations were

Calves deprived of Ig begin

development of active immunity at an earlier age, usually

beginning at 10 d of age (18). Serum IgG concentrations
were higher in calves on Pos treatment than calves on SQ Ig
treatments at both 48 h and 28 d.

Higher intake of Ig by

calves fed colostrum is probably responsible for this
difference.

Mean consumption of IgG and IgM of calves on

Pos treatment at 24 h of age were 164 g and 7 g,

respectively. Calves receiving SQ Ig obtained approximately
45 g of IgG and 5 g of IgM.

However, when efficiency of

absorption of IgG was calculated no significant differences
were seen between calves receiving Ig SQ and calves on Pos

treatment.

Mean apparent efficiency of absorption of IgG

(10) was 24.4% and 28.1% in calves fed colostrum and
receiving SQ Ig, respectively.

Serum IgM at 48 h post-injection tended (P < .10) to

be higher in calves injected with SQ Ig than in calves on

Neg treatment. Concentrations of IgM at 28 d were higher in
calves on the Neg treatment than calves on SQ Ig treatments

which may have been due to earlier endogenous IgM synthesis
in calves receiving no Ig.

immunoglobulin M is the first Ig

isotype to be synthesized by the calf (18).

Serum IgM

Table 6.

Least squares means of serum IgG and igM concentrations in colostrum-

deprived, colostrum-fed, and calves receiving subcutaneous immunoglobulin.
Treatment^

Contrasts

Neg

L30

S30

S60

Pos

SE

1

2

3

4

48 h^

1.1

4.2

4.4

4.0

14.6

.9

•k-k

•kk

NS®

NS

28 d

5.3

6.0

5.7

5.3

12.4

.9®

NS

•kk

NS

NS

48 h

.41

.74

.76

.62

1.02

.14

t

t

NS

NS

28 d

.80

.62

.66

.63

.53

.05'

*

t

NS

NS

Item^
Serum

Serum

IgG, g/L

IgM, g/L

^Treatments were subcutaneous (SQ) injections of:

.9% NaCl without colostrum

feeding (Neg), Ig (30 g/L) in Lactated Ringer's injection (L30), Ig (30 g/L) in .9%
NaCl (S30), and Ig (60 g/L) in .9% NaCl (S60), .9% NaCl with colostrum feeding

(Pos).

^Contrasts:

1 = SQ Ig treatments vs. Neg, 2 = SQ Ig treatments vs. Pos, 3 = 30 g

of Ig/L vs. 60 g of Ig/L, 4 = Saline vs. Lactated Ringer's injection at 30 g of
Ig/L.

^Means are covariately adjusted for BW at birth and serum IgG and IgM at 0 h.
^Serum Ig 48 h after administration of Ig.

'P > .10; +P < .10; *P < .05; "P < .01.
®SE = 1.0 for L30 and Neg, n = 5.
^SE = .06 for L30 and Neg, n = 5.

o^
(Jj
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concentrations were also higher among calves on Pos

treatment compared to calves on SQ Ig treatments for both 48

h and 28 d samples.

As with IgG, increased concentrations

may have been due to increased amounts of Ig consumed by
calves receiving colostrum.

In addition, serum IgG and IgM concentrations may have

been slightly higher in calves on Pos treatment than calves

on SQ Ig treatments due to a lower average birth BW.

Calves

on Pos treatment average 39.2 kg while calves on SQ Ig
treatment averaged 43.3 kg.

Also, the transfer of Ig

between interstitial fluid and plasma may differ relative to
route of administration.

Colostral proteins travel from the

intestinal lumen through the intestinal epithelium and

lymphatic system to the bloodstream before exchange with
interstitial fluid (12).

Proteins from SQ injection are

absorbed by the interstitium before exchange with plasma

(9).

In addition, interstitial fluid may contain as much as

40% of the Ig absorbed by the calf (12).

Glomeruli of

neonatal calves are permeable to macromolecules including Ig
(21).

This is evident since proteinuria occurs in the

neonate at the time of colostral absorption (21).

Finally,

catabolism and clearance of Ig by the liver and small

intestine may also account for Ig not found in serum.

Therefore, larger amounts of Ig in interstitial fluid,
catabolized or cleared via the kidney or small intestine may

account for the target Ig level of 15 mg of Ig/ml of plasma
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not being achieved.

In addition, plasma volumes were not

measured and may have been underestimated (2).

CONCLUSIONS

Subcutaneous injections of purified bovine Ig

increased serum IgG and IgM levels in colostrum deprived
calves.

However, these levels were not sufficient to

overcome failure of passive transfer.

Nevertheless, calves

who may have received some Ig from colostrum but still
experience failure of passive transfer may stand to benefit
from subcutaneous injections of purified bovine Ig by

achieving levels of 10 mg/ml or more.

Increasing the amount

of Ig injected may increase circulating levels to provide
greater protection for hypogammaglobulinemic calves.
Further study is required to determine the optimal route and
amount of administration and efficacy in maintaining animal
health.
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Respiration Rates (breaths/min)
Regression Analysis, LSMeans
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Rectal Temperatures (degree Celcius)
Regression Analysis, LSMeans
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Scours Scores (1-4)
Regression Analysis, LSMeans
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Grain Intake (g/d)
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Regression Analysis, LSMeans
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Milk Replacer Intake (g/d)
Regression Analysis, LSMeans
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Body Weight (Kg)
Regression Analysis, LSMeans
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